BetaShares FTSE 100 ETF (F100.AX) is an exchange-traded fund that seeks to provide investors with exposure to the performance of the FTSE 100 Index, comprising the 100 largest companies listed on the London Stock Exchange by market capitalization; the fund tracks the index before fees and expenses through a representative sampling methodology that holds a portfolio of the largest constituent securities. Its primary products and services include direct investment in FTSE 100 constituents such as multinational giants in sectors like financials, consumer goods, energy, healthcare, and industrials, with key holdings typically including brands like Shell, AstraZeneca, Unilever, HSBC, and BP; the ETF offers low-cost, passive investment vehicles for retail and institutional investors seeking UK large-cap equity exposure, daily liquidity on the ASX, and distributions derived from underlying dividends. BetaShares, the issuer headquartered in Sydney, Australia, and founded in 2009 as part of its broader suite of over 50 ETFs covering equities, fixed income, commodities, and alternatives, operates primarily in Australia with global asset exposure.
Geographic operations focus on tracking UK-listed companies with worldwide revenue streams, targeting Australian investors interested in diversified international equity allocation. Recent major developments include the fund's listing on the ASX in mid-2024 as part of BetaShares' expansion into international equity ETFs, enabling easier access to FTSE 100 performance amid heightened interest in UK markets post-Brexit and amid global diversification trends; no significant acquisitions, funding rounds, or name changes have been reported for the fund or issuer in the last 1-2 years, though BetaShares continues strategic growth through new ETF launches in response to investor demand for thematic and regional exposures.